ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $349 | -83.6% | 109,990 | -74.3% | 0.00% | -82.4% |
| Q2 2023 | $2,126 | -36.3% | 427,752 | -36.7% | 0.02% | -39.3% |
| Q1 2023 | $3,336 | -54.2% | 675,279 | -41.7% | 0.03% | -73.6% |
| Q4 2022 | $7,288 | -99.7% | 1,158,701 | +419.0% | 0.11% | +231.2% |
| Q3 2022 | $2,411,000 | +592.8% | 223,241 | +631.9% | 0.03% | +700.0% |
| Q2 2022 | $348,000 | -22.7% | 30,503 | -38.2% | 0.00% | -33.3% |
| Q1 2022 | $450,000 | -77.5% | 49,360 | -63.2% | 0.01% | -71.4% |
| Q4 2021 | $2,004,000 | +516.6% | 134,300 | +976.6% | 0.02% | +425.0% |
| Q2 2021 | $325,000 | -12.6% | 12,475 | +18.4% | 0.00% | -20.0% |
| Q1 2021 | $372,000 | – | 10,534 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |